X

Articles

19Jul

Sample submission during the national blood shortage

0 Comments | | Return |

Through communications with our clients, CTS is aware of the current national blood shortage. We realize this situation makes it even more critical that we report your results on time. While most test result reporting delays are CTS’ responsibility, there are ways you can help reduce delays.

We have noted that some test result delays are associated with an inadequate donor sample set. The two primary causes are when only two tubes instead of three are submitted for routine donations or when three tubes instead of four are submitted for donations requiring Babesia testing. Another scenario that causes delays is when three tubes are submitted but one is unacceptable for testing, which could be due to low fill volume, a serum tube that isn’t clotted, or an EDTA tube with micro-clots. These scenarios require the donor testing laboratories to share a tube between testing platforms, which adds significant time to complete testing. All these scenarios cause test result reporting delays of up to 12 hours.

We suggest a reminder to staff that, especially during this critical shortage of blood products nationally, it is very important to completely fill the required number of sample tubes and to completely mix the filled tubes to ensure sample acceptability is attained.

We are developing improved client reports that will indicate the number of inadequate donor sets submitted by your facility, so that you can assess the frequency of these problems. The new report will be available for July testing data per request.
 

Impact to the Clients: 

Client Action Required:

  • We suggest a reminder to staff that it is very important to completely fill the appropriate number of donor tubes.
  • We suggest a reminder to staff that it is very important to completely mix the filled tubes to ensure an acceptable sample for testing.

Contact your CSM with any questions!

Related

COVID-19 Antibody Testing Frequently Asked Questions

The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...

Read More >

2020 Annual CTS Survey

The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...

Read More >

CTS Dallas and Phoenix Labs Implements WNV Testing on the Panther

CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...

Read More >

Bio-Rad Geenius HIV 1/2 Implementation

CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...

Read More >

Reminder- The CTS Reentry form- CTS-00172 implements 7/2/18

Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...

Read More >

Updated Sample Acceptability Document

CTS was recently notified that one of the tubes listed in the Sample Acceptability document...

Read More >